Share of people with HIV who receive antiretroviral therapy in Oman
Oman: Share of people with HIV who receive antiretroviral therapy was 68.0% in 2024. ▲ Rising
Share of people with HIV who receive antiretroviral therapy in Oman, 2000–2024
Source: UNAIDS estimates, via World Bank (2026) – processed by Our World in Data. Measured in % of people living with HIV.
Analysis
The most recent figure for share of people with hiv who receive antiretroviral therapy in Oman is 68.0%, measured in 2024. That is the highest value across all 25 years on record.
That represents a change of up 6.2% on the previous year and up 88.9% over ten years.
Over the whole period, share of people with hiv who receive antiretroviral therapy in Oman peaked at 68.0% in 2024 and was at its lowest, 13.0%, in 2000.
That places Oman 82nd out of 143 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 25 years of available data.
Share of people with HIV who receive antiretroviral therapy in Oman, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 13.0% | — |
| 2001 | 14.0% | +7.7% |
| 2002 | 15.0% | +7.1% |
| 2003 | 15.0% | +0.0% |
| 2004 | 16.0% | +6.7% |
| 2005 | 17.0% | +6.2% |
| 2006 | 18.0% | +5.9% |
| 2007 | 20.0% | +11.1% |
| 2008 | 26.0% | +30.0% |
| 2009 | 31.0% | +19.2% |
| 2010 | 36.0% | +16.1% |
| 2011 | 33.0% | -8.3% |
| 2012 | 32.0% | -3.0% |
| 2013 | 35.0% | +9.4% |
| 2014 | 36.0% | +2.9% |
| 2015 | 34.0% | -5.6% |
| 2016 | 38.0% | +11.8% |
| 2017 | 41.0% | +7.9% |
| 2018 | 46.0% | +12.2% |
| 2019 | 54.0% | +17.4% |
| 2020 | 55.0% | +1.9% |
| 2021 | 60.0% | +9.1% |
| 2022 | 60.0% | +0.0% |
| 2023 | 64.0% | +6.7% |
| 2024 | 68.0% | +6.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 18.5% | 13.0% | 31.0% | 10 |
| 2010s | 38.5% | 32.0% | 54.0% | 10 |
| 2020s | 61.4% | 55.0% | 68.0% | 5 |
Countries ranked near Oman
More health data for Oman
- Un projection of annual infant deaths, annual growth rate -0.8969 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.3507 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 429.2 deaths per 1,000 people (2090)
- Number of infants who die before age 1 221 deaths (2100)
- Population ages 75-79, female, annual growth rate 4.76 % change on previous year (2025)
- Population ages 75-79, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, female, per capita 0.0025 units per person (2025)
- Population ages 75-79, male, annual growth rate 4.87 % change on previous year (2025)
- Population ages 75-79, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, male, per capita 0.0023 units per person (2025)
Frequently asked questions
- What is share of people with hiv who receive antiretroviral therapy in Oman?
- Share of people with hiv who receive antiretroviral therapy in Oman was 68.0% in 2024, according to UNAIDS estimates, via World Bank (2026) – processed by Our World in Data.
- What is the highest share of people with hiv who receive antiretroviral therapy recorded in Oman?
- The highest recorded value was 68.0% in 2024.
- What is the lowest share of people with hiv who receive antiretroviral therapy recorded in Oman?
- The lowest recorded value was 13.0% in 2000.
- How does Oman rank for share of people with hiv who receive antiretroviral therapy?
- Oman ranks 82nd out of 143 countries with data for 2024.
- Is share of people with hiv who receive antiretroviral therapy rising or falling in Oman?
- Over the last ten years it is up 88.9%. The long-run trend across the full record is rising.
- Where does this Oman data come from?
- The figures come from UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as part of Share of people with HIV who receive antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.